• 尊龙凯时人生就是搏·(中国区)官方网站

    Apeloa
    尊龙人生就是搏中国区药业
    CDMO
    API & Intermediate CDMO Finished Dosage Form Aesthetic & Care Ingredients
    About CDMO
    尊龙人生就是搏中国区药业
    尊龙人生就是搏中国区药业
    尊龙人生就是搏中国区药业
    尊龙人生就是搏中国区药业
    尊龙人生就是搏中国区药业
    Top 5
    player in small molecular field in China
    Apeloa CDMO is the contract manufacturing focused business of Apeloa, with strategically developed its business towards becoming one of the world's premier contract service organizations. Supported by a global network of manufacturing, development, and analytical facilities, Apeloa CDMO provides world-class discovery, development, and manufacturing services for Active Pharmaceutical Ingredients (APIs), Intermediates, and Registered Starting Materials (RSMs). The company's commitment to leading-edge science, best-in-class customer service, and regulatory compliance drives its success in the CDMO industry.
    420+
    customers globally
    3 global R&D centers: ● Boston, USA --- Function in Q2 2024; 16,000 sq ft; 40+ chemists in two years; Tech Development Platform/Lead optimization/Screening/Tox Batch preparation ● Shanghai, China --- 68,000 sq ft; 300+ chemists; Screening/Process development/optimization/CMC ● Hengdian, China --- 88,000 sq ft; 250+ chemists; Process optimization/Tech transfer/CMC
    One-Stop Service
    Apeloa CDMO offers comprehensive services covering the entire lifecycle, from drug discovery to commercial production. Includes Discovery Service, Chemistry Excellence, Chemical Process R&D, Custom and Commercial Production.
    尊龙人生就是搏中国区药业
    尊龙人生就是搏中国区药业
    尊龙人生就是搏中国区药业
    Technology Platforms
    Technology Platforms
    ApeloaApeloa
    Apeloa CDMO has built cutting-edge expertise and capabilities across a wide range of technical platforms to meet the market’s expectations. Our state-of-the-art facilities and expert teams ensure efficient and innovative solutions that advance customer molecules to market.
    尊龙人生就是搏中国区药业
    尊龙人生就是搏中国区药业
    尊龙人生就是搏中国区药业
    尊龙人生就是搏中国区药业
    Manufacturing Capacity
    8 manufacturing sites with cGMP, ISO9001, ISO14001, OSHAS18001 and IPMS certifications, 4 sites passed US FDA, 3 sites passed PMDA, 2 sites passed EDQM
    Total chemical synthesis capacity: 11,000 m³ (Stainless Steel/Glass/Hastelloy/Titanium alloy/Teflon)
    Total bio-production capacity: 6,570 m³ (Stainless Steel)
    3 new multi-functional API workshops for parallel productions at varied scales (658 m³ in total)
    High Potency API Facility for clinical & commercial scale (75 m³ in total)